BioLight Life Sciences Ltd. (TLV:BOLT)

SpringWorks Therapeutics Revenue

BioLight Life Sciences had revenue of 169.00K ILS in the twelve months ending March 31, 2025, up 6.96% year-over-year. In the year 2024, BioLight Life Sciences had annual revenue of 219.00K with 85.59% growth.

• Revenue (ttm): 169.00K
• Revenue Growth: +6.96%
• P/S Ratio: 150.04
• Revenue / Employee: 42.25K
• Employees: 4
• Market Cap: 25.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	219.00K	101.00K	85.59%
Dec 31, 2023	118.00K	55.00K	87.30%
Dec 31, 2022	63.00K	60.00K	2,000.00%
Dec 31, 2021	3.00K	-28.00K	-90.32%
Dec 31, 2020	31.00K	-	-